Protalix Biotherapeutics Inc
AMEX:PLX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Protalix Biotherapeutics Inc
AMEX:PLX
|
US |
|
Canadian National Railway Co
TSX:CNR
|
CA |
|
Dover Corp
NYSE:DOV
|
US |
|
Agricultural Bank of China Ltd
SSE:601288
|
CN |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
JP |
|
Frontdoor Inc
NASDAQ:FTDR
|
US |
|
Bank Negara Indonesia (Persero) Tbk PT
IDX:BBNI
|
ID |
|
Linamar Corp
TSX:LNR
|
CA |
|
Capri Holdings Ltd
NYSE:CPRI
|
UK |
|
Fairfax Financial Holdings Ltd
TSX:FFH
|
CA |
|
T
|
Tokyo Gas Co Ltd
TSE:9531
|
JP |
|
Covivio Hotels SCA
PAR:COVH
|
FR |
|
Dai-ichi Life Holdings Inc
TSE:8750
|
JP |
|
Rumble Inc
NASDAQ:RUM
|
US |
|
B
|
Bayer AG
F:BAYN
|
DE |
|
Murata Manufacturing Co Ltd
TSE:6981
|
JP |
|
Tsingtao Brewery Co Ltd
SSE:600600
|
CN |
|
Pro Medicus Ltd
ASX:PME
|
AU |
|
Diamondrock Hospitality Co
NYSE:DRH
|
US |
|
Zhejiang Supor Co Ltd
SZSE:002032
|
CN |
|
Sanmina Corp
NASDAQ:SANM
|
US |
|
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
|
US |
|
V
|
Venture Global Inc
NYSE:VG
|
US |
|
Toyota Industries Corp
TSE:6201
|
JP |
Bankruptcy Probability
Protalix Biotherapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Protalix Biotherapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
P
|
Protalix Biotherapeutics Inc
AMEX:PLX
|
172.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Protalix Biotherapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Protalix Biotherapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
